Search
European Commission Guidance: New Eligibility Tool and Early Information for joint clinical assessments
Joint Clinical Assessments (JCA) provide a framework for assessing clinical evidence on the relative effects of health technologies on health outcomes at the EU level. For medicinal products within the scope of the Health Technology Assessment (HTA) Regulation, health technology developers need to provide information early in the process so that the JCA can be prepared and the relevant HTA procedures can begin. The European Commission has updated its guidance on the submissio
Sharan Murugan
14 hours ago5 min read